Monday, June 6, 2016

BRIEF-Pfizer presents positive mid-stage data on merkel cell carcinoma drug at ASCO

* Pfizer inc says pivotal avelumab study shows positive

results in metastatic merkel cell carcinoma

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)